Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2010

May 27, 2010

34519_dirs_2010-05-27_b1f15027-9c0a-4bb4-ab24-7329af2b7dd0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-05-25

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-25 Common Stock, par value $0.10 per share P 200 $3.35 Acquired 461650 Direct
2010-05-25 Common Stock, par value $0.10 per share P 300 $3.30 Acquired 461950 Direct
2010-05-26 Common Stock, par value $0.10 per share P 400 $3.3472 Acquired 462350 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.

F2: This figure includes 214,155 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.